Prosight Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-72,116
Closed -$2.52M 44
2022
Q4
$2.52M Buy
+72,116
New +$2.52M 1.37% 22